Putting a Premium Valuation on Companies Managing Their Own ESG Risk
October 25, 2019
Prenner Bryant, Melody, Alfandary, Christina
Buying Solid Stocks When They Are Undervalued
May 10, 2019
Kahn, Thomas G.
Being More Selective and Focusing on Data in the Gene Therapy Space
April 05, 2019
Amusa, Gbola
Major Pharmas Becoming Increasingly Comfortable with Gene Therapy
March 22, 2019
Zhong, Yun
The First Half of 2019 Expected to Be Rough for the Biotech Sector
March 15, 2019
Singh, Hartaj
CRISPR and NASH Will Be Particularly Interesting and Exciting in 2019
March 15, 2019
Seedhouse, Steven
Building a Portfolio with Multiple Levels of Diversification
January 04, 2019
Cuggino, Michael J.
A Favorable Future for Today’s Leaner, More Data-Driven Biotechs
October 02, 2018
Selvaraju, Raghuram
Data Consistency is Important When Investing in Gene Therapy
March 21, 2018
Chattopadhyay, Debjit
Good Management Teams and Good Science are Creating Opportunities in Biotech
March 08, 2018
Singh, Hartaj
Biotech Space Lining Up for New Product Cycle
April 21, 2017
Singh, Hartaj
Looking for Growth, Consistency and Financial Strength
March 24, 2017
Maronak, Erick
A Cautious Perspective on the Biotechnology Sector
March 10, 2017
Shrader, Thomas
Applying Bottom-Up Fundamental Research in the Large-Cap Space
February 24, 2017
Fitzpatrick, Owen
Assuming a Higher Risk Profile if Tax Rates are Lowered
January 27, 2017
Havens, Peter H.
Investing for the Long Term in Biotechnology
October 21, 2016
Webb, Dallas
Seeking Global Equities with High Returns on Invested Capital
September 23, 2016
Perez Fernandez, Francisco Javier
Outperforming the Market with Less Volatility
September 09, 2016
Abelson, Adam S.
Critical Demand for Innovation in Pharma and Biotech
August 12, 2016
Brozak, Steve
Investing in Disruptive High-Growth Companies
April 08, 2016
Tubbs, Leslie
Supplementing a Growth-Oriented Portfolio with Out-of-Favor Sectors
January 29, 2016
Ray, Joseph H.
Using a Thematic Approach to Growth Investing
October 23, 2015
Kenneth D. Malamed
Finding Opportunities in Consistent Secular-Growth Companies
August 10, 2015
Opportunities in Regenerative Medicine, Cancer Immunotherapy Markets for Value Investors
July 06, 2015
Strong Fundamentals in Biotech Justify Even Higher Valuation Levels
December 11, 2014
Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014
Strong Outlook for Orphan and Oncology Treatments
April 03, 2014
Targeted Genetic and Cell Therapies Stand Out in Biotechnology
April 01, 2014
Buying Great Companies and Investing for the Long Term
March 27, 2014
A Health Care Convergence of Biotech, Pharma and Medical Devices
February 21, 2014
A Diversified Large-Cap Strategy with a Focus in Earnings
November 07, 2013
An Investment Strategy Focused On Capturing Positive Uptrends
October 08, 2013
Increased Biotech Productivity and Innovation Reflected in FDA-Approved Drugs
August 23, 2013
Oncology and Orphan Drugs Retain Pricing Power
August 14, 2013
Investing in Health Care Innovation
April 30, 2013
High Success Rates and Significant M&A in the Antibody Space
April 16, 2013
Opportunities in Hepatitis C and Genomic Technologies
April 08, 2013
Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan Drugs
April 05, 2013
Identifying Hidden Value and Market Opportunities in Biotech Companies
March 21, 2013
Utilizing Trends for Stock Selection Over the Longer Term
October 23, 2012
Hepatitis C Therapies Propel Growth in Biotech
August 30, 2012
Emerging-Growth Opportunities in Oncology Biotech
August 29, 2012
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
August 17, 2012
Innovation In Cardiovascular And Hepatic Devices And Drugs - Duane Nash - Wedbush Securities
November 21, 2011
"common Sense" Investment Management - Kendall J. Anderson - Anderson Griggs Portfolio Management
November 14, 2011
Capitalizing On The Secular Increase Of Time Spent Online - Herman Leung - Susquehanna Financial Group Lllp
October 17, 2011
Investing In Small- & Midcap Biotech Companies - Dr. Jason Kantor - Rbc Capital Markets
April 04, 2011
Technology Enablers Monetize Platform Shifts - Kerry Rice - Wedbush Securities
April 04, 2011
Continued M&a Activity In The Specialty Pharma Space - David Amsellem - Piper Jaffray & Co.
November 15, 2010
An Eye On Value & Long-term Growth In Health Services - Dr. Alastair Mackay - Garp Research & Securities
November 15, 2010
Risk Factors & Overheated Insurance Valuations - Peter Newell - Vontobel Asset Management, Inc.
May 17, 2010
A Close Look At Therapeutics Within Biotech - Matthew L. Kaplan - Ladenburg Thalmann & Co.
April 05, 2010
Investing In Commodities & Resources - James J. Puplava - Puplava Financial Services, Inc
November 02, 2009
Roundtable Forum: Midwest Banks
June 15, 2009
Investing In Large Cap Growth Stocks - Chris D. Bowen & Ryan Snow - Wasatch Funds
May 18, 2009
INVESTING IN DIABETES-RELATED STOCKS - DAVID A. KLIFF - DIABETIC INVESTOR
November 17, 2008
EQUITY INVESTMENT STRATEGIES FOR SMAS - ROBERT K. MADDOCK - INVERNESS COUNSEL, INC.
May 19, 2008
INVESTING IN LARGE CAP VALUE STOCKS - BRUCE W. KASER - VOYAGEUR ASSET MANAGEMENT INC.
March 10, 2008
SMALL & MICRO-CAP BIOTECHNOLOGY COMPANIES - GEORGE B. ZAVOICO - CANTOR FITZGERALD
February 25, 2008
INVESTING IN LARGE CAP GLOBAL OPPORTUNITIES - NICK ROBINSON - ABERDEEN ASSET MANAGEMENT
October 22, 2007
Investing In Growth Companies With Peg Ratio Valuation - Stephen Leeb - Leeb Capital Management, Inc.
July 23, 2007
SMALL CAP GROWTH INVESTING - JAMES A. BITZER - EGM CAPITAL, LLC
December 04, 2006
ROUNDTABLE FORUM: BROADCASTING
November 06, 2006
DIGITAL MARKETING TECHNOLOGY PROVIDERS - KYLE EVANS - STEPHENS INC.
November 06, 2006
CHARLES L. NORTON & ALLEN R. GILLESPIE - GNI CAPITAL, INC.
September 11, 2006
PULMONARY ARTERIAL HYPERTENSION: ANDREW FEIN - C.E. UNTERBERG, TOWBIN
July 03, 2006
RICHARD PARRY - TOM JOHNSON INVESTMENT MANAGEMENT
April 17, 2006
DAVID YUCIUS JR. - AURORA INVESTMENT COUNSEL
February 27, 2006
PACKAGED FOODS & AGRIBUSINESS: JOHN MCMILLIN - PRUDENTIAL EQUITY GROUP LLC
February 27, 2006
DENIS TURKO - HAVEN CAPITAL MANAGEMENT LLC
December 05, 2005
L.FRIDAY / P.SWANSON - KING INVESTMENT ADVISORS INC
November 14, 2005
EMERGING GROWTH LIFE SCIENCES COMPANIES: KEAY NAKAE - C.E. UNTERBERG, TOWBIN
October 25, 2005
ROUNDTABLE FORUM: WIRELESS EQUIPMENT
July 18, 2005
K.CRONK / T.LAPOINTE - COLUMBIA MANAGEMENT GROUP
June 27, 2005
ROUNDTABLE FORUM: BIOTECHNOLOGY
June 27, 2005
Oscar Spieler - Frontline Ltd (fro)
March 07, 2005
INVESTING IN SUNBELT COMMUNITY BANKS: J.DEMBA / G.TENNER - SUNTRUST ROBINSON HUMPHREY
September 28, 2004
OUTLOOK FOR PAPER & FOREST PRODUCTS: STEVE CHERCOVER - D.A.DAVIDSON & CO
September 20, 2004
KEVIN CAREY - 1ST SOURCE CORPORATION INVESTMENT ADVISORS INC
July 19, 2004
DEPARTMENT STORES, DISCOUNTERS & DOLLAR STORES: SHARI EBERTS - J.P. MORGAN CHASE
April 05, 2004
Small Cap Biotechnology Companies: Russell Gilbertson - Roth Capital Partners Llc
July 28, 2003
Marine Transport / Tanker Stocks: Jill Evans - J.p. Morgan Chase
April 14, 2003
Thomas Quealy Jr. - Elias Asset Management Inc
March 24, 2003
Robert Van Nostrand - Osi Pharmaceuticals Inc (osip)
September 13, 2002
Gold Stocks: Daniel Mcconvey - Goldman Sachs & Co
May 27, 2002
Ted Love - Hyseq Inc (hysq)
October 12, 2001
Power Technology & Services: Greg Haas - Raymond James & Associates
October 08, 2001
Dana Halberg / Michael Mohr - The Arden Group
September 03, 2001
Mark Frevert - Enron Wholesale Services (ene)
May 31, 2001
Michael Mcallister - Humana Inc (hum)
January 10, 2001
Doug Cahn - Reebok International Ltd (rbk)
December 25, 2000
Roundtable Forum: Investing In Gold Companies
December 25, 2000
E.o. Edgerton Jr. - Capital Investment Counsel Inc
August 14, 2000
Alfred Scheid - Scheid Vineyards Inc (svin)
August 14, 2000
Allen Ashcroft Jr. - Allied Investment Advisors
June 05, 2000
Malinda Berardino - Church Capital Management
March 27, 2000
Eric Miller - Heartland Advisors
December 20, 1999
Joseph J. Corasanti - Conmed Corporation (cnmd)
September 30, 1999
Vaughn M. Kailian - Cor Therapeutics Inc (corr)
December 14, 1998
